NCT02263378View on ClinicalTrials.gov

A New Supplement for the Immune Response to HPV Infection

NACompletedINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions

HPV Infection

Interventions

DRUG

ellagic acid + annona muricata

pills

All Listed Sponsors

lead

University of Messina

OTHER

NCT02263378 - A New Supplement for the Immune Response to HPV Infection | Biotech Hunter | Biotech Hunter